XML 24 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (77,002) $ (43,166) $ (6,399)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 7,736 8,026 8,012
Non-cash stock-based compensation expense 6,574 13,075 11,138
Loss on sale of assets 205 37 11
Deferred income taxes 977 (15,444) 4,193
Net gains on investment securities (5,289) (633) (2,839)
Equity in (earnings) losses from equity-method investments (36) 168 563
Distributions from equity-method investments 0 0 654
Non-cash interest expense 1,192 0 0
Non-cash lease expense 20,553 22,369 20,621
Change in fair value of derivative embedded within convertible debt 14,978 0 0
Provision for credit losses 5,241 4,712 4,064
Changes in assets and liabilities:      
Receivables 820 (2,173) 3,377
Income taxes receivables, net 5,292 1,174 (7,706)
Contract assets, net (5,988) 1,296 (12,183)
Accounts payable and accrued liabilities (6,904) 9,678 (22,734)
Operating right-of-use assets and operating lease liabilities, net (22,205) (22,664) (24,183)
Accrued salary and benefits (4,616) (5,316) (7,218)
Contract liabilities 19,578 (516) 16,682
Antitrust litigation settlement 10,000 0 0
Other 2,932 (1,038) (797)
Net cash used in operating activities (25,962) (30,415) (14,744)
Cash flows from investing activities:      
Investments in equity-method investments 0 0 (400)
Distributions from equity-method investments 0 0 75
Purchase of debt securities 0 (25) (701)
Proceeds from sale or liquidation of long-term investments 8,882 1,420 0
Purchase of equity securities 0 (300) (2,100)
Purchase of long-term investments (330) (190) (1,074)
Purchase of investment securities at fair value (9,804) 0 0
Capital expenditures (5,534) (6,143) (8,537)
Net cash used in investing activities (6,786) (5,238) (12,737)
Cash flows from financing activities:      
Proceeds from debt issuance 48,750 0 0
Repayment of debt 0 0 (12,528)
Deferred financing charges (1,997) 0 0
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting (1,301) (1,990) 0
Dividends on common stock 0 (4,222) (16,250)
Contributions from non-controlling interest 0 0 375
Earn out payments 0 0 (1,600)
Net cash provided by (used in) financing activities 45,452 (6,212) (30,003)
Net increase (decrease) in cash, cash equivalents and restricted cash 12,704 (41,865) (57,484)
Cash, cash equivalents and restricted cash, beginning of year 129,517 171,382 228,866
Cash, cash equivalents and restricted cash, end of year $ 142,221 $ 129,517 $ 171,382